PITTSBURGH, Dec. 20, 2011 /PRNewswire/ -- Mylan Inc.

PITTSBURGH, Dec. 1, 2011 /PRNewswire/ -- Mylan Inc.

An HIV-positive person who takes anti-retroviral drugs immediately after diagnosis, rather than waiting until their health begins to decline, can reduce the risk of spreading the virus to uninfected partners by 96%.

NEW ORLEANS, April 5, 2011 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (Takeda) announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate).

TITUSVILLE, N.J., Jan. 3, 2011 /PRNewswire/ -- The U.S.